| 2025-10-25 |
EMUIMU25S0024194 |
HALLSTAR C/O SEELER INDUSTRIES INC |
6425.0 kg |
291531.0
|
ETHYL METHOXY CRYLINE |
| 2025-10-10 |
CUIACTLHY2500194 |
SPECGX LLC |
2837.0 kg |
293740.0
|
CHEMICAL INTERMEDIATE D,L-THREO-RITALINIC ACID |
| 2025-10-07 |
MAEU258877874 |
RISING PHARMA HOLDINGS INC |
11046.07 kg |
830990.0
|
TOTAL PACKAGES BOTTLES PACKED IN SHIPPERS AND PACKED ON WOODEN PALLETS WI TH THERMAL BLANKETS CALCIUM ACETATE CAPSULES USP MG ( COUNT BOTTLES ) CAS NO. NDC NO. ANDA INV NO DT BUYERS ORDER NO DT HS CODE SB NO DT NET WT . KGS |
| 2025-09-15 |
MEDUKD052685 |
RISING PHARMA HOLDINGS INC |
7357.0 kg |
310510.0
|
BACLOFEN TABLETS MG S QUANTITY: . BOT BATCH NO: UBCTB A INVOICE NO: IN DT: - - BUYERS ORDER NO: DT: - - HS CODE: SB NO: DT: - - BACLOFEN TABLETS MG S QUANTITY: . BOT BATCH NO: UBCTB A BACLOFEN TABLETS MG S QUANTITY: . BOT BATCH NO: UBCTB A INVOICE NO: IN |
| 2025-09-09 |
NXGWHYDDCW03270 |
RISING PHARMA HOLDINGS INC |
2923.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR . ) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2025-09-02 |
NXGWHYDDCP18570 |
RISING PHARMA HOLDINGS INC |
2487.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR . ) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2025-08-11 |
NXGWHYDDBV76046 |
RISING PHARMA HOLDINGS INC |
2808.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2025-08-03 |
CUIACTLHY2500116 |
NORAMCO INC |
1673.0 kg |
750120
|
CHEMICAL INTERMEDIATE RITALINIC ACID |
| 2025-07-15 |
PGSMNSPNEW003800 |
NORAMCO INC |
3143.0 kg |
293339
|
HS CODE 29333990 CHEMICAL INTERMEDIATE RITAL INIC ACID |
| 2025-07-13 |
SIFKSMUM140751 |
INGENUS PHARMACEUTICALS LLC |
6253.0 kg |
|
ISOSORBIDE MONONITRATE EXTENDEDRELEASE |
| 2025-07-13 |
SIFKSMUM140756 |
INGENUS PHARMACEUTICALS LLC |
5502.0 kg |
930400
|
ISOSORBIDE MONONITRATE EXTENDED RELEASE TABL ETSUSP, |
| 2025-07-08 |
NXGWHYDDAT87294 |
RISING PHARMA HOLDINGS INC |
4558.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2025-07-01 |
NXGWHYDDAJ87185 |
RISING PHARMA HOLDINGS INC |
2746.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2025-06-30 |
KWEO530440075692 |
NORAMCO INC |
3074.0 kg |
750120
|
CHEMICAL INTERMEDIATE |
| 2025-05-14 |
NXGWHYDCYV22841 |
RISING PHARMA HOLDINGS INC |
614.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2025-05-08 |
TSYHBOM250302553 |
SPECGX LLC |
2818.0 kg |
293740
|
CHEMICAL INTERMEDIATE D,L-THREO-RITALINIC ACID |
| 2025-04-26 |
SIFKSMUM136235 |
INGENUS PHARMACEUTICALS LLC |
7914.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDED RELEASE TABLETS USP, |
| 2025-04-26 |
SIFKSMUM136299 |
INGENUS PHARMACEUTICALS LLC |
5417.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDED RELEASE TABLETS USP |
| 2025-04-13 |
NXGWHYDCXW64811 |
RISING PHARMA HOLDINGS INC |
1248.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2025-04-08 |
PGSMNSPEWR215015 |
SPECGX LLC |
2820.0 kg |
293339
|
CHEMICAL INTERMEDIATE D,L-THREO-RITALINIC ACID HS CODE. 29333990 |
| 2025-04-08 |
PGSMNSPEWR214996 |
NORAMCO INC |
3582.0 kg |
293339
|
CHEMICAL INTERMEDIATE RITALINIC ACID HS CODE 29333990 |
| 2025-03-30 |
NXGWHYDCXH18661 |
RISING PHARMA HOLDINGS INC |
2572.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2025-03-18 |
CMDUAMC2350475 |
RISING PHARMA HOLDINGS INC |
12024.0 kg |
300490
|
CARGO IS STOWED IN A REFRIGERATED CONTAINER STHE SHIPPER S REQUESTED CARRYING TEMPERATURE DEGREES CELSIUS 38 PALLETS CONSISTING OF 125352 BOTTLES BACLOFEN TABLETS USP 5MG (100 S COUNT) QUANTITY: 21960.000BOT BATCH NO: UBCTA4020A BACLOFEN TABLETS USP 5MG ( |
| 2025-03-02 |
NXGWHYDCWH17131 |
RISING PHARMA HOLDINGS INC |
1193.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2025-02-13 |
SIFKSMUM133511 |
INGENUS PHARMACEUTICALS LLC |
39.0 kg |
310510
|
ISOSORBIDE MONONITRATEEXTENDED RELEASE TABLETS |
| 2025-01-18 |
NXGWHYDCVG91090 |
RISING PHARMA HOLDINGS INC |
1083.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2024-12-17 |
MEDUVW100873 |
RISING PHARMA HOLDINGS INC |
7779.0 kg |
300490
|
41 PALLETS CONSISTING OF 106296 BOTTLES EPLERENONE TABLETS 25MG (30 S COUNT) QUANTITY:4272.000BOT BATCH NO:UEPTA4001A EPLERENONE TABLETS 25MG (30 S COUNT) QUANTITY:4176.000BOT BATCH NO:UEPTA4002A EPLERENONE TABLETS 25MG (30 SCOUNT) QUANTITY:2472.000BOT BATCH NO:UEPTA40 03A EPLERENONE TABLETS 25MG (90 S COUNT) QUAN TITY:552.000BOT BATCH NO:UEPTA4003B EPLERENONE TABLETS 50MG (30 S COUNT) QUANTITY:3168.000BOT BATCH NO:UEPTB4001A EPLERENONE TABLETS 50MG (30 S COUNT) QUANTITY:3624.000BOT BATCH NO:UEPTB4002A EPLERENONE TABLETS 50MG (30 S COUNT) QUANTITY:1728.000BOT BATCH NO:UEPTB4003A EPLERENONE TABLETS 50MG (90 S COUNT) QUANTITY:480.000BOT BATCH NO:UEPTB4003B INV NO:IN3600 000555 DT:30-10-2024 BUYERS ORDER NO:4500014184 DT:13-02-2024 HS CODE:30049049 SB NO:5321557 DT:01-11-2024 BACLOFEN TABLETS USP 10MG (1000 S COUNT) QUANTITY:4080.000BOT BATCH NO:UBCTB4014A INV NO:IN3600000556 DT:30-10-2024 BUYERS ORDER NO:4500015304 DT:08-09-2024 HS CODE:30049099 SB NO:5321536 DT:01-11-2024 BACLOFEN TABLETS USP 10MG (100 S COUNT) QUANTITY:40 752.000BOT BATCH NO:UBCTB4015A BACLOFEN TABLETS USP 10MG (100 S COUNT) QUANTITY:40992.000BOT BATCH NO:UBCTB4018A INV NO:IN3600000557 DT:30-10-2024 BUYERS ORDER NO:4500015144 DT:19-07-2024 HS CODE:30049099 SB NO:5321537 DT:01-11-2024 NET WT: 6959.822 KGSNAC: RISING PHARMACEUTICALS THE TEMPERATURE TO BE SET AT PLUS 20 DEGREE CELSIUS IN ACCORDANCE WITH SHIPPER S INSTRUCTION |
| 2024-12-02 |
ALPJMUMCHS00227 |
JANSSEN PHARMACEUTICAL INC |
6725.0 kg |
844711
|
HDPE BLUE OPEN TOP DRUMS |
| 2024-11-25 |
NXGWHYDCSM75052 |
RISING PHARMA HOLDINGS INC |
1193.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2024-09-28 |
KEONKMNYC240017H |
NORAMCO INC |
5372.0 kg |
293339
|
CHEMICAL INTERMEDIATE RITALINIC ACID. HS CODE. 29333990 |
| 2024-08-27 |
DSVFHYD8017963 |
AVET PHARMACEUTICALS |
2955.0 kg |
|
PHARMA |
| 2024-08-27 |
DSVFHYD8017962 |
AVET PHARMACEUTICALS |
2207.0 kg |
|
PHARMA |
| 2024-07-14 |
EMUIMU24S0010128 |
SPECGX LLC |
2821.0 kg |
293624
|
CHEMICAL INTERMEDIATE D,LTHREORITALINIC ACID . |
| 2024-06-07 |
SIFKSMUM122571 |
INGENUS PHARMACEUTICALS LLC |
5813.0 kg |
310510
|
ISOSORBIDE MONONITRATE TABLETS UPS |
| 2024-06-07 |
SIFKSMUM122572 |
INGENUS PHARMACEUTICALS LLC |
6131.0 kg |
310510
|
ISOSORBIDE MONONITRATE ER TABLETS |
| 2024-06-05 |
SIFKSMUM122519 |
INGENUS PHARMACEUTICALS LLC |
6674.0 kg |
310510
|
ISOSORBIDE MONONITRATE ER TABLETS |
| 2024-05-25 |
EMUIMU24S0000016 |
CHEMO S A DE C V |
2278.0 kg |
110320
|
VENLAFAXINE HYDROCHLORIDE SR PELLETS 33 TARI . |
| 2024-05-25 |
EMUIMU23S0042295 |
CHEMO S A DE C V |
2278.0 kg |
271600
|
ELECTRICAL TEMPERATURE CONTROLLER. |
| 2024-05-18 |
MEDUJ7346243 |
RISING PHARMA HOLDINGS INC |
7128.0 kg |
300490
|
39 PALLETS CONSISTING OF 1 09720 BOTTLES BA CLOFEN T ABLETS, USP 10MG (1000 S C OUNT) B ACLOFEN TABLETS, USP 10MG (100 S COUNT) B A CLOFEN TABLETS, USP 5MG ( 100 S COUNT) BACL OFEN TA BLETS, USP 5MG (100 S COUN T) BACLO FEN TABLETS, USP 5MG (100 S COUNT) INV N O: IN3600000728 DT:29-03-20 24 BUYERS ORDER NO :45000 13919 DT:02-01-2024 BATC H NO:UBCTB4 007A,UBCTB4004A ,UBCTA4003A,UBCTA4002A,UBC TA4001A H.S CODE:3004909 9 SB NO:8767138 DT :30-03 -2024 NET WT: 6348.833 K GS NAC: R ISING PHARMACEU TICALS THE TEMPERATURE TO BE SET AT PLUS 18 DEGREE C ELCIUS IN ACCORDANCE WITH SHIPPER S INSTRUCTION |
| 2024-05-04 |
SIFKSMUM121626 |
CHETAK NEW YORK LLC |
6081.0 kg |
|
ISOSORBIDE MONONITRATE EXTENTEDRELEASETABLE TS |
| 2024-05-04 |
SIFKSMUM121622 |
INGENUS PHARMACEUTICALS LLC |
7038.0 kg |
|
ISOSORBIDE MONONITRATE EXTENTED RELEASETABLETS |
| 2024-05-04 |
SIFKSMUM121624 |
CHETAK NEW YORK LLC |
4923.0 kg |
|
ISOSORBIDE MONONITRATE EXTENTEDRELEASETABLETS |
| 2024-03-08 |
SIFKSMUM118719 |
INGENUS PHARMACEUTICALS LLC |
7257.0 kg |
|
ISOSORBIDE MONONITRATE EXTENTED RELEASETABLETSUSP |
| 2024-03-08 |
SIFKSMUM118716 |
INGENUS PHARMACEUTICALS LLC |
6889.0 kg |
930400
|
ISOSORBIDE MONONITRATE EXTENTED RELEASE TABLETSUSP 30MG |
| 2024-03-08 |
SIFKSMUM118718 |
INGENUS PHARMACEUTICALS LLC |
6704.0 kg |
|
ISOSORBIDE MONONITRATE EXTENTED RELEASETABLETSUSP |
| 2024-03-08 |
SIFKSMUM118717 |
INGENUS PHARMACEUTICALS LLC |
5683.0 kg |
291229
|
ISOSORBIDE MONONITRATE EXTENTED RELEASETABLE TS USP 30MG |
| 2023-12-09 |
EMUIMU23S0027994 |
|
2569.0 kg |
292221
|
OMEPRAZOLE DR PELLETSS 8.5. |
| 2023-11-28 |
SIFKSMUM114815 |
INGENUS PHARMACEUTICALS LLC |
5963.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDED RELEASE TABLETS |
| 2023-11-16 |
MOSJS00032093 |
DCS 4277 HGHWAY |
7700.0 kg |
300490
|
HS CODE 30049099 METHOCARBAMOL TABLETS USP 7 . |
| 2023-11-08 |
SIFKSMUM113573 |
INGENUS PHARMACEUTICALS LLC |
3464.0 kg |
|
ISOSORBIDE MONONITRATE EXTENDED RELEASETABLE TS |